National Cancer Institute (NCI) – As an important part of the National Institutes of Health (NIH), the NCI is the Federal Government's principal agency for cancer research and training. The NCI's research programs are extensive and contain many innovative initiatives on malignant neoplasms of the B-lymphocyte lineage, including B-cell lymphoma, Waldenström's macroglobulinemia and multiple myeloma.

International Waldenström's Macroglobulinemia Foundation (IWMF) – The IWMF offers caring support for patients with Waldenström's macroglobulinemia (WM) and promotes enhanced understanding of WM by supporting basic medical and scientific research into the causes, treatments, and potential cures for WM.

Multiple Myeloma Research Foundation (MMRF) – The MMRF is the largest nonprofit foundation dedicated to accelerating the search for a cure for multiple myeloma. Through the building of interdisciplinary collaborations, the MMRF is expanding therapeutic treatments for myeloma and extending the lives of multiple myeloma patients worldwide.

UI/Mayo Lymphoma SPORE – The University of Iowa/Mayo Clinic (UI/MC) Lymphoma SPORE is a long-standing translational cancer research program that brings together basic laboratory, clinical and population-based investigators who share an interest in the design and testing of new approaches to the treatment and prevention of malignant lymphoma and chronic lymphocytic leukemia. 

(See complete publications list at PubMed